Injective says it leads all major blockchains on 2026 revenue relative to fully diluted value, ahead of Solana and over | Hanami
Injective says it leads all major blockchains on 2026 revenue relative to fully diluted value, ahead of Solana and over 8x Ethereum. The revenue funds its monthly INJ Community BuyBack, which removes INJ from supply.
@injective